Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China

PaperCitations, authors & open-access status

Chimeric Antigen Receptor 4SCAR-GD2-Modified T Cells Targeting High-Risk and Recurrent Neuroblastoma: A Phase II Multi-Center Trial in China is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 24 citations, 2017 year and closed oa status.

24
Citations
2017
Year
closed
OA Status

Related on ScholarIQ

Maoquan Qin
Author
Blood
Journal
Neuroblastoma Research and Treatments
Topic
Neuroblastoma Research and Treatments
Topic
CAR-T cell therapy research
Topic
470M+ articles · free account